Back to News
Mar 2, 2026 8:10 AM

UroGen Pharma: Q4 Earnings Insights

The Q4 earnings report for UroGen Pharma (NASDAQ:URGN) was released on Monday, March 2, 2026 at 08:00 AM.

Here's what investors need to know about the latest announcement.

Earnings

UroGen Pharma beat estimated earnings by 5.26%, reporting an EPS of $-0.54 versus an estimate of $-0.57.

Revenue was up $13.27 million from the same period last year.

Earnings History Overview

The company beat ...